MedTrace Logo

Theophylline in Treating Cancer Patients With Shortness of Breath

NCT00003684 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2020-04-03

No results posted yet for this study

Summary

RATIONALE: Theophylline may help to relieve shortness of breath in patients who have cancer. It is not yet known whether theophylline is more effective than no further treatment for shortness of breath.

PURPOSE: Randomized phase III trial to determine the effectiveness of theophylline in treating shortness of breath in patients who have cancer.

Conditions

  • Pulmonary Complications
  • Quality of Life
  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

theophylline

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • NCIC Clinical Trials Group

    lead NETWORK

Principal Investigators

  • Deborah J. Dudgeon, MD, RN · Cancer Research Institute at Queen's University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-03-24
Primary Completion
2008-12-15
Completion
2008-12-15

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003684 on ClinicalTrials.gov